CLOs on the Move

Oyster Point Pharma

www.oysterpointrx.com

 
Based in Princeton, New Jersey, Oyster Point Pharma is a clinical stage pharmaceutical company leveraging neuroscience to discover, develop and commercialize novel therapies to treat diseases with high unmet needs. The company`s initial focus is to develop innovative therapeutics to treat the signs and symptoms of Dry Eye Disease (DED) by stimulating the trigeminal parasympathetic pathway to activate the glands responsible for tear film production. Oyster Point is leveraging a class of receptors called nicotinic acetylcholine receptors (nAChRs) which are located on the trigeminal nerve, accessible within the nose, to stimulate natural tear film production. The two lead product candidates, ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Raegan McClain
 Vice President and Chief Ethics, Compliance and Risk Management Officer Profile
Barry Rosenfeld
 Senior Director, Corporate Counsel Profile
Barry Rosenfeld
 Senior Vice President and General Counsel Profile
Jill Andersen
 General Counsel and Chief Compliance Officer Profile
Jill Andersen
 General Counsel, Corporate Secretary and Chief Compliance Officer Profile

Similar Companies

Little Leaves Behavioral Services

Vision RT

Vision RT is the inventor of Surface Guided Radiation Therapy (SGRT) and produces a range of innovative solutions to improve radiation therapy.

Fusion MD Network

Fusion MD Network is a Montreal, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

ARTMS

ARTMS Inc. is the global leader in the development of novel technologies and products for enabling the cyclotron production of the world’s most-used diagnostic imaging isotopes.

ABIGO MEDICAL AB

ABIGO MEDICAL AB is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.